Caribou Biosciences, Inc.
CRBU • NASDAQ • Stock Fundamentals
Caribou Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rachel E. Haurwitz, with a market cap of $164.6M.
Market Cap$164.6M
Employees137.0
CEORachel E. Haurwitz
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Caribou Biosciences, Inc. FAQ
Common questions about Caribou Biosciences, Inc.
Caribou Biosciences, Inc. (CRBU) has a market capitalization of $164.6M and trades on NASDAQ.
Caribou Biosciences, Inc. has approximately 137 employees.